Results 1 to 4 of 4

Thread: 6 oxo?

  1. #1
    charlesriley's Avatar
    charlesriley is offline Associate Member
    Join Date
    Oct 2009
    Posts
    305

    6 oxo?

    anyone got the up n up on this, theres alot of web info but if you can give ur 2cents bout this i would appreciate it.

  2. #2
    Swifto's Avatar
    Swifto is offline Banned- Scammer!
    Join Date
    Oct 2004
    Location
    Anywhere...
    Posts
    15,725
    Its a bit of a wierd compounds. It raises testosterone (free, total) but doesnt completely reduce aromotase, although it does the above by that mechanism.


    J Int Soc Sports Nutr. 2007 Oct 19;4:13.

    Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males.

    Rohle D, Wilborn C, Taylor L, Mulligan C, Kreider R, Willoughby D.

    Department of Health, Human Performance, and Recreation, Baylor University, Box 97313, Waco, TX 76798, USA. [email protected].

    ABSTRACT: The purpose of this study was to determine the effects of 6-OXO, a purported nutritional aromatase inhibitor, in a dose dependent manner on body composition, serum hormone levels, and clinical safety markers in resistance trained males. Sixteen males were supplemented with either 300 mg or 600 mg of 6-OXO in a double-blind manner for eight weeks. Blood and urine samples were obtained at weeks 0, 1, 3, 8, and 11 (after a 3-week washout period). Blood samples were analyzed for total testosterone (TT), free testosterone (FT), dihydrotestosterone (DHT), estradiol, estriol, estrone, SHBG, leutinizing hormone (LH), follicle stimulating hormone (FSH), growth hormone (GH), cortisol, FT/estradiol (T/E). Blood and urine were also analyzed for clinical chemistry markers. Data were analyzed with two-way MANOVA. For all of the serum hormones, there were no significant differences between groups (p > 0.05). Compared to baseline, free testosterone underwent overall increases of 90% for 300 mg 6-OXO and 84% for 600 mg, respectively (p < 0.05). DHT underwent significant overall increases (p < 0.05) of 192% and 265% with 300 mg and 600 mg, respectively. T/E increased 53% and 67% for 300 mg and 600 mg 6-OXO, respectively. For estrone, 300 mg produced an overall increase of 22%, whereas 600 mg caused a 52% increase (p < 0.05). Body composition did not change with supplementation (p > 0.05) and clinical safety markers were not adversely affected with ingestion of either supplement dose (p > 0.05). While neither of the 6-OXO dosages appears to have any negative effects on clinical chemistry markers, supplementation at a daily dosage of 300 mg and 600 mg for eight weeks did not completely inhibit aromatase activity, yet significantly increased FT, DHT, and T/E.

    PMID: 17949492 [PubMed - in process]



    Its not a good addition to PCT IMHO.

  3. #3
    warchild's Avatar
    warchild is offline Knowledgeable Member
    Join Date
    Jun 2008
    Posts
    5,964
    they found boldenone in it a study, nothing more than a mild AI

  4. #4
    charlesriley's Avatar
    charlesriley is offline Associate Member
    Join Date
    Oct 2009
    Posts
    305

    Lightbulb

    [QUOTE=Swifto;4925720]Its a bit of a wierd compounds. It raises testosterone (free, total) but doesnt completely reduce aromotase, although it does the above by that mechanism.


    J Int Soc Sports Nutr. 2007 Oct 19;4:13.

    Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males.

    Rohle D, Wilborn C, Taylor L, Mulligan C, Kreider R, Willoughby D.

    Department of Health, Human Performance, and Recreation, Baylor University, Box 97313, Waco, TX 76798, USA. [email protected].

    ABSTRACT: The purpose of this study was to determine the effects of 6-OXO, a purported nutritional aromatase inhibitor, in a dose dependent manner on body composition, serum hormone levels, and clinical safety markers in resistance trained males. Sixteen males were supplemented with either 300 mg or 600 mg of 6-OXO in a double-blind manner for eight weeks. Blood and urine samples were obtained at weeks 0, 1, 3, 8, and 11 (after a 3-week washout period). Blood samples were analyzed for total testosterone (TT), free testosterone (FT), dihydrotestosterone (DHT), estradiol, estriol, estrone, SHBG, leutinizing hormone (LH), follicle stimulating hormone (FSH), growth hormone (GH), cortisol, FT/estradiol (T/E). Blood and urine were also analyzed for clinical chemistry markers. Data were analyzed with two-way MANOVA. For all of the serum hormones, there were no significant differences between groups (p > 0.05). Compared to baseline, free testosterone underwent overall increases of 90% for 300 mg 6-OXO and 84% for 600 mg, respectively (p < 0.05). DHT underwent significant overall increases (p < 0.05) of 192% and 265% with 300 mg and 600 mg, respectively. T/E increased 53% and 67% for 300 mg and 600 mg 6-OXO, respectively. For estrone, 300 mg produced an overall increase of 22%, whereas 600 mg caused a 52% increase (p < 0.05). Body composition did not change with supplementation (p > 0.05) and clinical safety markers were not adversely affected with ingestion of either supplement dose (p > 0.05). While neither of the 6-OXO dosages appears to have any negative effects on clinical chemistry markers, supplementation at a daily dosage of 300 mg and 600 mg for eight weeks did not completely inhibit aromatase activity, yet significantly increased FT, DHT, and T/E.

    PMID: 17949492 [PubMed - in process]



    Its not a good addition to PCT IMHO.[/QUOT

    good find, thanks

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •